Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A narrative review of emerging therapeutics for COVID-19.
Willis VC, Arriaga Y, Weeraratne D, Reyes F, Jackson GP. Willis VC, et al. Among authors: weeraratne d. Mayo Clin Proc Innov Qual Outcomes. 2020 Jul 20. doi: 10.1016/j.mayocpiqo.2020.07.004. Online ahead of print. Mayo Clin Proc Innov Qual Outcomes. 2020. PMID: 32838206 Free PMC article. Review.
Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program.
Vashistha V, Poonnen PJ, Snowdon JL, Skinner HG, McCaffrey V, Spector NL, Hintze B, Duffy JE, Weeraratne D, Jackson GP, Kelley MJ, Patel VL. Vashistha V, et al. Among authors: weeraratne d. PLoS One. 2020 Jul 24;15(7):e0235861. doi: 10.1371/journal.pone.0235861. eCollection 2020. PLoS One. 2020. PMID: 32706774 Free PMC article.
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment.
Koyama T, Weeraratne D, Snowdon JL, Parida L. Koyama T, et al. Among authors: weeraratne d. Pathogens. 2020 Apr 26;9(5):324. doi: 10.3390/pathogens9050324. Pathogens. 2020. PMID: 32357545 Free PMC article.
Precision Medicine, AI, and the Future of Personalized Health Care.
Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, Zhao J, Snowdon JL. Johnson KB, et al. Among authors: weeraratne d. Clin Transl Sci. 2020 Sep 22. doi: 10.1111/cts.12884. Online ahead of print. Clin Transl Sci. 2020. PMID: 32961010 Review.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK; VERTIS CV Investigators. Cannon CP, et al. N Engl J Med. 2020 Oct 8;383(15):1425-1435. doi: 10.1056/NEJMoa2004967. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966714 Clinical Trial.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, Bisch JA, Richardson T, Jaros M, Wijngaard PLJ, Kastelein JJP; ORION-10 and ORION-11 Investigators. Ray KK, et al. N Engl J Med. 2020 Apr 16;382(16):1507-1519. doi: 10.1056/NEJMoa1912387. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187462 Clinical Trial.
Iron diapirs entrain silicates to the core and initiate thermochemical plumes.
Fleck JR, Rains CL, Weeraratne DS, Nguyen CT, Brand DM, Klein SM, McGehee JM, Rincon JM, Martinez C, Olson PL. Fleck JR, et al. Among authors: weeraratne ds. Nat Commun. 2018 Jan 4;9(1):71. doi: 10.1038/s41467-017-02503-2. Nat Commun. 2018. PMID: 29302028 Free PMC article.
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessments.
Kroenke MA, Weeraratne DK, Deng H, Sloey B, Subramanian R, Wu B, Serenko M, Hock MB. Kroenke MA, et al. Among authors: weeraratne dk. J Immunol Methods. 2017 Jun;445:37-44. doi: 10.1016/j.jim.2017.03.005. Epub 2017 Mar 6. J Immunol Methods. 2017. PMID: 28274835 Clinical Trial.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference.
Weeraratne DK, Lofgren J, Dinnogen S, Swanson SJ, Zhong ZD. Weeraratne DK, et al. J Immunol Methods. 2013 Oct 31;396(1-2):44-55. doi: 10.1016/j.jim.2013.07.010. Epub 2013 Aug 6. J Immunol Methods. 2013. PMID: 23933325
16 results
Jump to page